Parallel, one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced its national partnership with Cannaclusive, the leading organization created to facilitate inclusion for both business owners and consumers in the cannabis industry.
New cannabis-infused lotions provide Texas patients with convenient topical doses of THC and CBD for conditions such as spasticity, multiple sclerosis, terminal cancer, and ALS
New cannabis-infused lozenges provide Texas patients with convenient sublingual doses of THC and CBD for conditions such as terminal cancer, spasticity, autism, epilepsy, and incurable neurological diseases.
The collaboration between a leading cannabis company and a reputable organization focused on education for business leaders in the cannabis industry will develop educational programming in addition to communication and media opportunities for industry professionals and the wider Florida medical community.
Parallel will provide $3 million in grant funding for clinical studies on sickle cell disease, anxiety and other chronic illnesses; obtains license to operate in Pennsylvania
